Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$63.75 - $108.06 $11.4 Million - $19.3 Million
178,309 New
178,309 $12.5 Million
Q2 2023

Aug 04, 2023

BUY
$32.62 - $40.75 $287,382 - $359,007
8,810 Added 697.55%
10,073 $328,000
Q1 2023

Apr 27, 2023

BUY
$33.36 - $45.71 $42,133 - $57,731
1,263 New
1,263 $44,000
Q1 2022

May 02, 2022

SELL
$29.74 - $46.0 $706,622 - $1.09 Million
-23,760 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$34.35 - $46.38 $874,963 - $1.18 Million
-25,472 Reduced 51.74%
23,760 $1.08 Million
Q3 2021

Oct 28, 2021

BUY
$18.54 - $35.74 $101,932 - $196,498
5,498 Added 12.57%
49,232 $1.03 Million
Q2 2021

Aug 12, 2021

BUY
$19.79 - $26.99 $612,421 - $835,232
30,946 Added 241.99%
43,734 $865,000
Q1 2021

Apr 26, 2021

BUY
$18.57 - $25.68 $237,473 - $328,395
12,788 New
12,788 $0
Q4 2020

Feb 02, 2021

SELL
$15.26 - $28.61 $462,316 - $866,768
-30,296 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$20.58 - $28.96 $569,201 - $800,975
27,658 Added 1048.45%
30,296 $655,000
Q2 2020

Jul 13, 2020

SELL
$11.15 - $24.64 $477,654 - $1.06 Million
-42,839 Reduced 94.2%
2,638 $62,000
Q1 2020

Apr 29, 2020

SELL
$8.75 - $16.3 $111,947 - $208,542
-12,794 Reduced 21.96%
45,477 $536,000
Q4 2019

Feb 05, 2020

BUY
$7.95 - $11.84 $409,234 - $609,475
51,476 Added 757.56%
58,271 $618,000
Q3 2019

Oct 15, 2019

BUY
$10.82 - $14.25 $73,521 - $96,828
6,795 New
6,795 $77,000
Q2 2019

Jul 26, 2019

SELL
$7.95 - $11.25 $1,812 - $2,565
-228 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$5.95 - $10.19 $1,356 - $2,323
228 New
228 $0
Q3 2018

Oct 23, 2018

SELL
$6.4 - $9.85 $31,769 - $48,895
-4,964 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$6.9 - $9.9 $29,414 - $42,203
4,263 Added 608.13%
4,964 $41,000
Q1 2018

Apr 26, 2018

SELL
$7.2 - $10.05 $26,942 - $37,607
-3,742 Reduced 84.22%
701 $5,000
Q4 2017

Jan 10, 2018

SELL
$7.25 - $15.65 $9,084 - $19,609
-1,253 Reduced 22.0%
4,443 $36,000
Q3 2017

Oct 25, 2017

BUY
$12.0 - $15.0 $68,352 - $85,440
5,696
5,696 $82,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.61B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.